Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HGT-1410 Extension in Pediatric MPS IIIA
NCT02350816Phase 2Terminated
- Sponsor
- Takeda
- Start
- Apr 2015
- Primary completion
- Apr 2019
- Modality
- Replacement Enzymes
- Countries
- 7
01
Overview
A Phase 2 trial of recombinant human heparan-N-sulfatase in mucopolysaccharidosis type III A, sponsored by Takeda. Started Apr 2015; status: terminated.
02
Drugs
recombinant human heparan-N-sulfatase
03
Conditions
mucopolysaccharidosis type III A
Beyond the preview
Go deeper on NCT02350816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02350816.